SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parmax Pharma - Quaterly Results

14 Aug 2024 Evaluate
The total revenue for the June 2024 quarter zoomed 458.29% to Rs. 78.16 millions as compared to Rs. 14.00 millions during the year-ago period.The Total Profit for the quarter ended June 2024 of Rs. 0.12 millions grew from Rs.-11.79 millions Operating profit Margin for the quarter ended June 2024 improved to 5.21% as compared to -6.38% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 78.16 14.00 458.29 78.16 14.00 458.29 110.53 154.24 -28.34
Other Income 0.08 0.14 -42.86 0.08 0.14 -42.86 0.48 0.40 20.00
PBIDT 5.21 -6.38 -181.66 5.21 -6.38 -181.66 -33.23 22.93 -244.92
Interest 1.13 1.22 -7.38 1.13 1.22 -7.38 6.22 3.69 68.56
PBDT 4.08 -7.60 -153.68 4.08 -7.60 -153.68 -39.45 19.24 -305.04
Depreciation 3.96 4.19 -5.49 3.96 4.19 -5.49 17.12 18.79 -8.89
PBT 0.12 -11.79 -101.02 0.12 -11.79 -101.02 -56.57 0.45 -12671.11
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.95 1.50 -36.67
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.95 -0.35 -371.43
PAT 0.12 -11.79 -101.02 0.12 -11.79 -101.02 -57.52 -1.05 5378.10
Equity 37.41 37.41 0.00 37.41 37.41 0.00 37.41 37.41 0.00
PBIDTM(%) 6.67 -45.57 -114.63 6.67 -45.57 -114.63 -30.06 14.87 -302.23

Parmax Pharma Share Price

68.02 1.33 (1.99%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: